Synthesis and biological activity of pyr
β
Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. OβNeill;
π
Article
π
2011
π
Elsevier Science
π
English
β 705 KB
The development and synthesis of potent p38Ξ± MAP kinase inhibitors containing a pyridazinone platform is described. Evolution of the p38Ξ± selective pyridopyridazin-6-one series from the p38Ξ±/Ξ² dual inhibitor 2H-quinolizin-2-one series will be discussed in full detail.